Alcohol consumption had no beneficial effect on serum lipids in a substantial proportion of patients with primary hyperlipidemia

Journal of Clinical Epidemiology

Volumn 53, Issue 10, 2000, Pages 1020-1024

  Sijbrands, Eric J G ^a   Smelt, Augustinus H M ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alcohol; Cigarette smoking; Cross sectional study; High density lipoprotein; Primary hyperlipidemia

Indexed keywords

HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; FEMALE; HEART PROTECTION; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ALCOHOL DRINKING; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LINEAR MODELS; LIPOPROTEINS, HDL CHOLESTEROL; MALE; MIDDLE AGE; RISK FACTORS; SMOKING;

EID: 0033807292     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(00)00196-7     Document Type: Article

References (19)

1. Renaud S., De Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 339:1992;1523-1526.
2. Criqui M.H., Ringel B.L. Does diet or alcohol explain the French paradox? Lancet. 344:1994;1719-1723.
3. Leger A.S., Cochrane A.L., Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet. i:1979;1017-1020.
4. Rimm E.B., Giovannuci E.L., Willett W.C., Colditz G.A., Rosner B. Prospective study of alcohol consumption and risk of coronary heart disease in men. Lancet. 338:1991;464-468.
5. Fuchs C.S., Stampfer M.J., Colditz G.A., Giovannuci E.L., Manson J.E., Kawachi I.et al. Alcohol consumption and mortality among women. N Engl J Med. 332:1996;1245-1250.
6. Gaziano J.M., Buring J.E., Breslow J.L., Goldhaber S.Z., Rosner B., VanDenburgh M.et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 329:1993;1829-1834.
7. Savolainen M.J., Kesaniemi Y.A. Effects of alcohol on lipoproteins in relation to coronary artery disease. Curr Opin Lipidol. 6:1995;243-250.
8. 2 and postheparin lipolytic activity by constant moderate alcohol intake. Schweiz Med Wochenscr. 114:1984;1930-1932.
9. Kervinen K., Savolainen M.J., Kesaniemi Y.A. A rapid increase in lipoprotein (a) levels after ethanol withdrawal in alcoholic men. Life Sci. 48:1991;2183-2188.
10. Nishiwaki M., Ishikawa T., Ito T. A remarkable increase in high-density lipoprotein-cholesterol (HDL-C) by alcohol intake in a homozygous patient with cholesteryl ester transfer protein (CETP) deficiency. Ann NY Acad Sci. 748:1995;626-629.
11. Anonymous Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med. 148:1988;36-69.
12. Mahley RW, Rall SC, Jr. Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. 7th Edition. New York, NY, USA: McGraw-Hill, 1995; 1953-80.
13. Sijbrands E.J.G., Westendorp R.G.J., Hoffer M.J.V., Frants R.R., Meinders A.E., Souverijn J.H.M.et al. Effect of apolipoprotein E and insulin resistance on VLDL particles in combined hyperlipidemic patients. Atherosclerosis. 126:1996;197-205.
14. Tan K. Hypertriglyceridaemia and vascular risk. Epidemiology of triglycerides and coronary heart disease. Lancet. 342:1993;781-782.
15. Craig W.Y., Palomaki G.E., Haddow J.E. Cigarette smoking and serum lipid and lipoprotein concentrations. an analysis of published data BMJ. 298:1989;784-788.
16. Freeman D.J., Packard C.J. Smoking and plasma lipoprotein metabolism. Clin Science. 89:1995;333-342.
17. Axelsen M., Eliasson B., Joheim E., Lenner R.A., Taskinen M.R., Smith U. Lipid intolerance in smokers. J Intern Med. 237:1995;449-455.
18. Hill J.S., Hayden M.R., Frohlich J., Pritchard P.H. Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia. Arterioscler Thromb. 11:1991;290-297.
19. Nobili A., D'Avanzo B., Santoro L., Ventura G., Todesco P., La Vecchia C. Serum cholesterol and acute myocardial infarction. a case-control study from the GISSI-2 trial Br Heart J. 71:1994;468-473.